These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Catching the missing million: experiences in enhancing TB & DR-TB detection by providing upfront Xpert MTB/RIF testing for people living with HIV in India. Raizada N; Sachdeva KS; Sreenivas A; Kulsange S; Gupta RS; Thakur R; Dewan P; Boehme C; Paramsivan CN PLoS One; 2015; 10(2):e0116721. PubMed ID: 25658091 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Xpert MTB/RIF assay in children with presumed pulmonary tuberculosis in Papua New Guinea. Kasa Tom S; Welch H; Kilalang C; Tefuarani N; Vince J; Lavu E; Johnson K; Magaye R; Duke T Paediatr Int Child Health; 2018 May; 38(2):97-105. PubMed ID: 28490246 [TBL] [Abstract][Full Text] [Related]
9. The New Xpert MTB/RIF Ultra: Improving Detection of Chakravorty S; Simmons AM; Rowneki M; Parmar H; Cao Y; Ryan J; Banada PP; Deshpande S; Shenai S; Gall A; Glass J; Krieswirth B; Schumacher SG; Nabeta P; Tukvadze N; Rodrigues C; Skrahina A; Tagliani E; Cirillo DM; Davidow A; Denkinger CM; Persing D; Kwiatkowski R; Jones M; Alland D mBio; 2017 Aug; 8(4):. PubMed ID: 28851844 [TBL] [Abstract][Full Text] [Related]
10. "Before Xpert I only had my expertise": A qualitative study on the utilization and effects of Xpert technology among pediatricians in 4 Indian cities. McDowell A; Raizada N; Khaparde SD; Rao R; Sarin S; Kalra A; Salhotra VS; Nair SA; Boehme C; Denkinger CM PLoS One; 2018; 13(3):e0193656. PubMed ID: 29547642 [TBL] [Abstract][Full Text] [Related]
11. Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study. van Kampen SC; Susanto NH; Simon S; Astiti SD; Chandra R; Burhan E; Farid MN; Chittenden K; Mustikawati DE; Alisjahbana B PLoS One; 2015; 10(6):e0123536. PubMed ID: 26075722 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Theron G; Peter J; van Zyl-Smit R; Mishra H; Streicher E; Murray S; Dawson R; Whitelaw A; Hoelscher M; Sharma S; Pai M; Warren R; Dheda K Am J Respir Crit Care Med; 2011 Jul; 184(1):132-40. PubMed ID: 21493734 [TBL] [Abstract][Full Text] [Related]
13. Retrospective Diagnostic Accuracy Study of Abbott RealTi Howlett P; Nabeta P; Tukvadze N; Schumacher SG; Denkinger CM Microbiol Spectr; 2021 Sep; 9(1):e0013221. PubMed ID: 34406811 [TBL] [Abstract][Full Text] [Related]
14. Use of Xpert MTB/RIF in Decentralized Public Health Settings and Its Effect on Pulmonary TB and DR-TB Case Finding in India. Sachdeva KS; Raizada N; Sreenivas A; Van't Hoog AH; van den Hof S; Dewan PK; Thakur R; Gupta RS; Kulsange S; Vadera B; Babre A; Gray C; Parmar M; Ghedia M; Ramachandran R; Alavadi U; Arinaminpathy N; Denkinger C; Boehme C; Paramasivan CN PLoS One; 2015; 10(5):e0126065. PubMed ID: 25996389 [TBL] [Abstract][Full Text] [Related]
15. Performance of the Xpert MTB/RIF assay in the diagnosis of tuberculosis in formalin-fixed, paraffin-embedded tissues. Polepole P; Kabwe M; Kasonde M; Tembo J; Shibemba A; O'Grady J; Kapata N; Zumla A; Bates M Int J Mycobacteriol; 2017; 6(1):87-93. PubMed ID: 28317811 [TBL] [Abstract][Full Text] [Related]
16. Comparison of Xpert MTB/RIF with other nucleic acid technologies for diagnosing pulmonary tuberculosis in a high HIV prevalence setting: a prospective study. Scott LE; McCarthy K; Gous N; Nduna M; Van Rie A; Sanne I; Venter WF; Duse A; Stevens W PLoS Med; 2011 Jul; 8(7):e1001061. PubMed ID: 21814495 [TBL] [Abstract][Full Text] [Related]
17. Low prevalence of MDR-TB in Lao PDR: results from the first national anti-tuberculosis drug resistance survey. Iem V; Dean A; Zignol M; Vongvichit P; Inthavong D; Siphanthong S; Sorsavanh T; Kim SJ; Shin S; Sébert J; Chittamany P Trop Med Int Health; 2019 Apr; 24(4):421-431. PubMed ID: 30663180 [TBL] [Abstract][Full Text] [Related]
18. Diagnostic accuracy of Xpert MTB/RIF for extrapulmonary tuberculosis specimens: establishing a laboratory testing algorithm for South Africa. Scott LE; Beylis N; Nicol M; Nkuna G; Molapo S; Berrie L; Duse A; Stevens WS J Clin Microbiol; 2014 Jun; 52(6):1818-23. PubMed ID: 24622091 [TBL] [Abstract][Full Text] [Related]
19. A cost-benefit algorithm for rapid diagnosis of tuberculosis and rifampicin resistance detection during mass screening campaigns. Donkeng-Donfack VF; Tchatchueng-Mbougua JB; Abanda NN; Ongboulal SM; Djieugoue YJ; Kamdem Simo Y; Mekemnang Tchoupa M; Bekang Angui F; Kuate Kuate A; Mbassa V; Mvondo Abeng Belinga E; Eyangoh S BMC Infect Dis; 2022 Mar; 22(1):219. PubMed ID: 35246071 [TBL] [Abstract][Full Text] [Related]
20. Effect of the Xpert MTB/RIF on the detection of pulmonary tuberculosis cases and rifampicin resistance in Shanghai, China. Wu Z; Rueda ZV; Li T; Zhang Z; Jiang Y; Sha W; Yu F; Chen J; Pan Q; Shen X; Yuan Z BMC Infect Dis; 2020 Feb; 20(1):153. PubMed ID: 32070292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]